Could cause temporary or reversible harm; serious harm is unlikely.
Subpotent Drug
| Brand name | LEVOTHYROXINE SODIUM |
| Generic name | LEVOTHYROXINE SODIUM |
| Active ingredient(s) | LEVOTHYROXINE SODIUM |
| Distributed by / for | Accord Healthcare, Inc., Raleigh, NC 27617 |
| NDC | 16729-458-15 |
| Full product label | Levothyroxine Sodium Tablets, USP, 300 mcg (0.3mg), 90 Tablets bottles, Rx only, Manufactured for: Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: lntas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, INDIA, NDC 16729-458-15. |
| Recalling firm | ACCORD HEALTHCARE, INC. |
| Distribution | US Nationwide. |
| Quantity | 6432 bottles |
| Recall initiated | 2026-06-08 |
| Report date | 2026-07-08 |
| Recall completed | — |
| Recall number | D-0656-2026 |
| Classification | Class II |
| FDA status | Ongoing |
| Origin on file | Raleigh NC United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗